key: cord-0895860-2l56vj20
authors: Schwab, Kristin; Schwitzer, Emily; Qadir, Nida
title: Post-Acute Sequelae of COVID-19 Critical Illness
date: 2022-01-10
journal: Crit Care Clin
DOI: 10.1016/j.ccc.2022.01.001
sha: 5e353c24b8202807555e3046d50d739c2ebe7d87
doc_id: 895860
cord_uid: 2l56vj20

With an ever-increasing number of COVID-19 survivors, providers are tasked with addressing the longer lasting symptoms of COVID-19, or post-acute sequelae of SARS-CoV-2 infection (PASC). For critically ill patients, existing knowledge about post-intensive care syndrome (PICS) represents a useful structure for understanding PASC. Post-ICU clinics leverage a multidisciplinary team to evaluate and treat the physical, cognitive, psychological sequelae central to both PICS and PASC in critically ill patients. While management through both pharmacologic and nonpharmacologic modalities can be utilized, further research into both the optimal treatment and prevention of PASC represents a key public health imperative.

Coronavirus disease 2019 (COVID-19) has claimed over 4 million deaths worldwide 1 and has created an unprecedented burden on intensive care units globally. 2 Much of the dialogue surrounding the pandemic has centered on mortality, which has been as high as 50% in critically ill patients. 3 However, most patients will survive acute illness from COVID-19, and survival, despite being a desired outcome, is also fraught with challenges. Initial reports from Italy, France, and the United States suggest that 66-87% of hospitalized patients with COVID-19 have symptoms that persist after hospital discharge. [4] [5] [6] The term "long COVID" has helped to raise awareness of the post-acute sequelae of SARS-CoV-2 infection (PASC) and the potentially longlasting health consequences that can stem from acute illness. Particularly in patients surviving COVID-19 critical illness, survival will not equate to recovery, and understanding and addressing the long-term needs of survivors is a societal imperative. While PASC has been reported even among patients who were not critically ill or hospitalized, this review focuses on PASC in critically ill COVID patients.

combination of the two. 31, 34 While the prevalence varies widely based on patient population, risk factors, and methods used for diagnosis, it is believed that 43% of patients in the ICU suffer from this complication, which is associated with both hospital mortality and long-term mortality, with decreased survival seen in patients up to five years later. 35, 36 Consequently, patients have difficulties performing their daily activities with persistently lower health-related quality of life (HRQL) measures when compared to age matched norms. 37, 38 In areas hit hard by the pandemic, ICU staffing shortages may contribute to limited patient mobilization, a preventative measure known to reduce the risk of ICU-acquired weakness. 39 Indeed, the receipt of care in overwhelmed and understaffed hospitals has been associated with adverse outcomes. 25, 40 Other risk factors for long-term physical sequelae of critical illness in COVID-19 survivors include frequent use of prone positioning and arterial line placement, which can each increase the risk of neuropathy. 41 Corticosteroids and prolonged used of neuromuscular blocking agents, which are prescribed to treat COVID-19 pneumonia and manage severe acute respiratory distress syndrome, respectively, further increase the risk of CIM when used in combination. 42, 43 Psychological Impairment The psychologic sequelae of PICS are estimated to occur in up to a third of survivors, with PTSD, depression, and anxiety as the predominant conditions. 13, 44 While it can be situational for some, others have symptoms that persist for months to years after discharge, disrupting daily functioning and reducing overall quality of life; ICU survivors also have a higher incidence of suicide and self-harm when compared to hospital survivors who never required ICU admission. 45, 46 The psychological sequelae extend beyond the patient to those in the family as well, collectively known as PICS-Family (PICS-F). 7 Having a critically ill family member has been shown to have profound effects on relatives, with over two thirds reporting anxiety or depression when visiting their loved ones, and 30% suffering from anxiety, depression, or PTSD beyond discharge. 47, 48 Further, the complex interactions of the various domains of PICS, as outlined above, amplify the burden on patient's families as well as dramatically increase the cost for healthcare systems. 49,50 COVID-19 patients have similarly been found to have high rates of PTSD, anxiety, depression, and insomnia, likely due to both disease-specific and pandemic-related factors including stigmatization, social isolation, and media sensationalism, among others. 51 Existing studies suggest that approximately 30%, 20%, 13%, and 27% of COVID-19 survivors suffer from anxiety, depression, PTSD, and insomnia, respectively. 26 As PICS has profound effects across mental, cognitive, and physical domains, a first step involves recognizing the comorbidities that predispose to developing it in the first place. To date, there have been many studies evaluating the risk factors associated with PICS, although the mechanisms continue to be poorly understood. While certain risk-factors are pre-existing and thus non-modifiable, others are ICU-specific, and thus have the potential to be optimized ( Figure  2 ). 13,52-54 For example, delirium, which is associated with increased mortality, ICU length of stay, and long-term cognitive impairment, may represent one modifiable risk factor. 12,55-57 As such, multicomponent ICU-level strategies, such as the 'ABCDEF bundle,' have been employed with success. 12, 56 This systematic method of pain assessment, both spontaneous awakening and breathing trials, choosing safe and effective medication regimens for managing pain and agitation, delirium monitoring, exercise/early mobility, and family engagement, has been shown to reduce the amount of sedative use, duration of delirium, and ICU length of stay. [58] [59] [60] With the COVID-19 pandemic bringing a growing number of patients to the ICU, it is becoming increasingly imperative to identify additional modifiable risk factors for PICS so that new preventative interventions can be developed in the future.

While symptoms of PICS may improve over time, survivors of critical illness still face a number of long-term challenges, including increased mortality, rehospitalization, reduced quality of life, and financial loss. A study of US Medicare beneficiaries comparing ICU survivors to age, sex, and race-matched controls from the general population found that ICU survivors have increased mortality at 3 years (39.5% vs 14.9%); 61 similar findings were seen in Dutch 62 and Scottish 63 cohorts. Long-term mortality in mechanically ventilated ICU survivors is markedly increased, with rates of 41-58% reported in multicenter cohorts. 61, 64, 65 Similarly, healthcare utilization, including hospital readmission, increases after critical illness. In an observational study comparing healthcare utilization among ICU survivors before and after critical illness, ICU survivors in the year following critical illness were found to have an increase in outpatient visits, emergency department visits, and hospitalizations of 8%, 33%, and 60%, respectively, when compared to the prior year. 66 Expectedly, post-discharge healthcare costs are also greater than costs in the year prior to critical illness. Less predictably, healthcare costs can remain increased from baseline for up to 5 years following discharge. 63 Functional status and HRQL also suffer after critical illness. [67] [68] [69] [70] [71] [72] [73] [74] At least partial disability in activities of daily living is seen in one-fifth of previously independent individuals one year after discharge. 69 Frailty, which is associated with new-onset disability, 75 is also common among survivors of critical illness. In a recent multicenter study, transition to a state of increased frailty occurred in 40% of ICU survivors at one year, including 23% of patients who were not frail at baseline. 76 Likewise, HRQL is worse in ICU survivors compared with population norms. However, it remains unclear to what degree post-ICU HRQL is a reflection of pre-morbid quality of life. HRQL has also been found to improve over time, particularly during the first year following ICU discharge. 68, [71] [72] [73] COVID-19 patients similarly suffer from increased healthcare utilization and risk of death, with estimates suggesting a 1 in 5 risk of readmission and a 1 in 10 risk of death among hospitalized COVID-19 patients in the first 60 days after discharge. 77 Beyond readmission and death, survivors also have decreased HRQL, increased outpatient healthcare visits, and increased pharmacotherapy utilization, including opioid pain medications, antidepressants, anxiolytics, and more. 78, 79 

The COVID-19 pandemic has brought increased attention to the role of socioeconomic status in critical illness. Indeed, lower socioeconomic position and social vulnerability are associated with increased risk of critical illness and death from COVID-19 infection. 80, 81 However, an inverse relationship between socioeconomic position and health outcomes in ICU survivors has previously been established, with lower socioeconomic position associated with increased risk of long-term mortality and reduced HRQL. 82, 83 Just as socioeconomic status affects outcomes in the critically ill, critical illness itself has an impact on subsequent social and economic outcomes. Job loss and delayed return to work are common after critical illness, likely a result of post-ICU impairments. Of patients who were previously employed, only 56-60% return to work one year after critical illness, and one-third remain jobless after 5 years. 84, 85 While the long-term work implications in critically ill COVID-19 survivors are still being investigated, preliminary evidence suggests similar findings, with less than half of critically-ill COVID-19 patients returning to work at 3-4 months after discharge. 79 Consequently, loss of income is common, reported in 71% of ICU survivors in the year following critical illness, 86 as are other elements of financial toxicity, such as loss of healthcare coverage, depletion of savings, and medical bills. [86] [87] [88] Family structure and roles may be also altered, as one-quarter of ICU survivors report needing a caregiver one year after critical illness. The vast majority of care is provided by family members, half of whom report a resultant negative impact on employment. 89, 90 

While limited evidence exists to inform the optimal evaluation of PASC, significant experience in the post-ICU arena can help guide these efforts. 91 Indeed, to evaluate for PICS and the constellation of downstream effects outlined above, post-ICU clinics have been developed. 92 Guidelines from the United Kingdom recommend that all adults who have stayed in an ICU for more than 4 days be followed after discharge, though implementation barriers have hampered widespread adoption of this policy in the UK and elsewhere. 93 As many patients transfer first to facilities such as skilled nursing facilities or acute rehabilitation units before discharging to home, coordinating the ideal timing of the first post-ICU visit can be challenging. Consensus guidelines recommend an assessment 2-4 weeks after hospital discharge. 94 Experience from centers specializing in post-ICU care suggests that a discharge navigator can be particularly useful in identifying and recruiting eligible patients, 95, 96 and may be associated with decreased readmission rates and decreased loss to follow-up. 96 The navigator role may be filled by one of many different providers, including nurse practitioners, social workers, respiratory therapists, or case managers. In this role, the provider can connect with patients while still hospitalized, schedule and share information about the post-ICU clinic visit, and serve as a point of contact for the patients and their families as they navigate the transition out of the hospital. In settings where access to post-ICU follow-up may be more limited, navigators may choose to screen for risk factors to identify patients at particularly high risk for PICS and prioritize these patients for follow-up.

To address all of the components of PICS, post-ICU clinics are typically composed of a multidisciplinary team. Providers have debated which medical specialty is best equipped to lead these clinics (i.e., intensivists versus rehabilitation specialists), yet this debate seems to only further highlight the importance of the interdisciplinary approach. 97, 98 We believe it is important to incorporate an ICU provider in the clinic, as studies suggest that this can facilitate longitudinal care delivery for patients, circle back to improve processes for future patients in the ICU, and reduce ICU staff burnout. 92, 99, 100 In addition to an intensivist, a number of other clinicians typically comprise the multidisciplinary team, including a specialist to assess for physical debility (e.g., a physical therapist, physiatrist, and/or respiratory therapist), psychological sequelae (e.g., a psychologist and/or social worker), and cognitive impairment (e.g., an occupational therapist, speech/language pathologist, or neurocognitive specialist). Additional team members may include a pharmacist, nutritionist, chaplain, case manager, or palliative care specialist.

During the clinic visit, standardized tools should be adopted to systemically evaluate for PICS and track progression over time (Figure 3 ). Although further research into the optimal assessment tools are needed, guidelines have been developed based upon expert opinion. 94, 101 Current guidelines recommend using the Hospital Anxiety and Depression Scale (HADS) to assess for anxiety and depression, as well as either the Impact of Events Scale-Revised (IES-R) or the shorter IES-6 to evaluate for post-traumatic stress disorder. 94, 101 While expert consensus has not been reached regarding the optimal cognitive screening tool, the Montreal Cognitive Assessment (MOCA) or MOCA-Blind may be used to screen for cognitive impairment. 94 To evaluate for physical and pulmonary function, the Society of Critical Care Medicine suggests using the six minute walk test; 94 our center also uses bedside spirometry and the Modified Medical Research Council dyspnea scale as further assessments of pulmonary function. Some experts also suggest further evaluation of ICU-acquired weakness, including CIM and CIN, through the use of manual muscle testing and handgrip dynamometry; our center also utilizes the Borg Balance Scale (BBS) and Five Times Sit to Stand (5XSTS) instruments for further assessment of physical disability. 101 Finally, the EuroQol-5D (EQ-5D) questionnaire can be used to evaluate both HRQL and pain. 101 In addition to using these screening assessments, a complete medication reconciliation should be performed to reduce the risk of polypharmacy. Our center's practice also includes evaluation for new or persistent symptoms, appropriate referrals to further assist with ongoing physical and medical recovery, and screening for healthcare maintenance gaps such as immunizations. To help educate the patient and family, we summarize the patient's ICU course, counsel on expected ICU recovery and supports available, and answer any questions. We also include family members in this process, as the adverse psychological effects that an ICU stay can have on family members, or PICS-Family, have become increasingly appreciated. 7 Finally, we ask for feedback to help with ongoing quality improvement efforts within the ICU.

While these appointments have traditionally been performed in-person, the expanding role of telemedicine amidst the COVID-19 pandemic has opened up possibilities for expanding the reach of post-ICU clinics. 102 This can be particularly useful in the post-ICU population, where limited patient mobility, large geographical distances, financial strain, and reduced access to transportation services can make in-person visits challenging. 103

As PICS and PASC remain relatively novel concepts, much of the management rests on expert opinion or extrapolation from other specialties. Similar to the multidisciplinary approach to assessment that is outlined above, a cross-disciplinary approach incorporating both pharmacological and non-pharmacological domains will often need to be utilized.

In treating cognitive dysfunction, the provider should first evaluate for and manage any potentially reversible etiologies. This includes psychiatric conditions such as depression that can manifest with cognitive dysfunction, polypharmacy that may occur due to inadvertentlycontinued ICU medications on discharge (e.g., atypical antipsychotics), sleep disorders, and metabolic or nutritional disturbances. Once these have been addressed, other treatment options such as cognitive therapy and exercise can be considered. Cognitive rehabilitation therapy aims to improve thought processes and behavior through multimodal strategies such as memory training exercises and/or the incorporation of organizational devices like phone reminders. 104 This has been evaluated in a limited number of studies on ICU survivors and may lead to improvements in cognitive functioning, and particularly executive function, though further studies are needed. 105 For appropriate patients, exercise therapy has been shown to improve cognitive function in patients with mild cognitive impairment, and may similarly be of benefit to patients with PICS-associated cognitive impairment. 106 We typically refer patients with ongoing physical limitations to physical therapy and/or occupational therapy for ongoing recovery, with the acknowledgement that there are limited studies for rehabilitation in CIM and CIN at present. 107 In addition, randomized trials of rehabilitation-based programs for ICU survivors have not yet shown benefit for HRQL metrics. [108] [109] [110] Nevertheless, given its potential to improve functional capacity, we continue to recommend physical and occupational therapy in this patient population. Rehabilitation specialists may also assist with recommendations regarding mobility aides and environmental adjustments. For COVID-19 survivors specifically, providers should avoid prolonging corticosteroid courses in the outpatient setting unless an alternative condition such as organizing pneumonia exists. 111 In addition, given parallels between myalgic encephalomyelitis/chronic fatigue syndrome and the fatigue that many recovering COVID-19 patients describe, patients should be counseled on the importance of graded exercise increase to decrease the risk of setbacks and post-exertional malaise. 112 Patients with pulmonary limitations due to post-ARDS fibrosis are managed with both supportive and preventative care. The prevalence of post-ARDS fibrosis in patients with and without COVID-19 remains unclear, but can be evaluated with serial pulmonary function testing and imaging. 113 Thus far, evidence suggests that the majority of these patients experience improvement in both physiologic testing and radiographic changes improve over time. 114, 115, 67 In this population, providers can thus assist with oxygen weaning, radiographic and pulmonary function test follow-up, and pulmonary rehabilitation referrals when indicated. Pulmonary rehabilitation, which involves supervised graded aerobic exercise training, strength training, and education on topics such as breathing techniques, inhaler use, and red flag symptoms, has been shown to improve pulmonary function and HRQL in ARDS survivors. 116 We also ensure that vaccinations against streptococcus pneumoniae, influenza, and COVID-19 are up to date. In spite of these measures, a minority of patients might not improve and may ultimately need to be referred to a center specializing in interstitial lung disease.

Patients with persistent psychiatric impairments after ICU survival benefit from referral to a mental health professional for appropriate management. Treatment frequently involves a combination of pharmacotherapy and psychotherapy. Patients with depression can be treated with either an antidepressant or psychotherapy alone, as each has shown efficacy in randomized trials, though data also suggests that combination therapy may be more efficacious than either treatment individually. [117] [118] [119] For anxiety, cognitive behavioral therapy remains the most studied, and thus first-line, psychotherapeutic option, though mindfulness-based therapies are gaining increasing attention and may be more feasible for patients to initiate themselves during the initial recovery period. 120 Pharmacotherapy for generalized anxiety disorder may also be considered for patients who meet diagnostic criteria. First-line treatment for post-traumatic stress disorder involves trauma-focused therapies such as cognitive behavioral therapy and exposure-based therapy, with medications reserved for individuals with a strong preference towards this. 121 Some post-ICU centers also offer peer support groups through either in-person or virtual platforms, which have been shown to have a myriad of beneficial effects for patients. 122, 123 An additional challenge we have found during the COVID-19 pandemic is that after discharge, recovered patients are frequently hesitant to leave their homes due to fear of contracting the virus again, inadvertently restricting their opportunities for mobilization, which can exacerbate deconditioning and functional limitations, and also lead to worsened quality of life. In these situations, providers should evaluate for anxiety, agoraphobia, and PTSD and refer for treatment when applicable. They can also reinforce masking and social distancing precautions, and assess for appropriate COVID-19 vaccination timing. We have also found that a minority of patients can become consumed with media reports and social medial rabbit holes on long COVID, which often focus on outlier patients and can thus paint an overly negative picture of COVID-19 recovery. Similar stressors have been described in survivors of the SARS pandemic. 124 Providers can assist by counseling patients on expected recovery trajectory, normalizing their experience, and validating their progress. 125

In response to the COVID-19 pandemic, multidisciplinary post-ICU clinics have been newly created by centers worldwide. 40 While these clinics currently serve a crucial role in meeting the needs of patients recovering from COVID-19, they also provide a number of opportunities for improving care for all critically ill patients. On a center-level, previously undetected issues can be identified during outpatient follow-up and serve as targets for ICU quality improvement. From the standpoint of clinician education, witnessing a patient's recovery process may result in greater reflective practice in the ICU, influencing clinical decision-making and improving accuracy in predicting outcomes. 126 Post-ICU clinics also provide a much-needed avenue for conducting long-term outcomes research, which has been methodologically challenging in critical care. Loss to follow-up is a common limitation in long-term ICU outcomes studies, likely resulting in the exclusion of some of the most severely ill patients, who may have physical or cognitive deficits leading to study withdrawal. 127 Such patients may potentially be more likely to present for clinical care than for research follow-up. As more patients survive critical illness, improving care in the ICU will increasingly need to focus on preventing morbidity, and creating additional opportunities for post-discharge assessment is invaluable. The proliferation of post-ICU clinics during the COVID-19 pandemic may ultimately help improve care for all critically ill patients (Figure 4 ).

Conclusion Amidst a growing appreciation of the wide-ranging and long-term public health effects of COVID-19, PICS represents a useful contextual framework for diagnosing and treating PASC in critically ill survivors of COVID-19. While these conditions are not one and the same, there is substantial overlap, and providers can draw upon existing knowledge of PICS when treating COVID-19 survivors. Further research into prevention, diagnosis, and treatment of both PICS and PASC are needed as we move into the new frontier of COVID-19 survivorship. 

Global Impact of Coronavirus Disease

Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis

Outcomes of Patients With Coronavirus Disease 2019 Receiving Organ Support Therapies: The International Viral Infection and Respiratory Illness Universal Study Registry

Persistent Symptoms in Patients After Acute COVID-19

Follow-up of adults with noncritical COVID-19 two months after symptom onset

Sixty-Day Outcomes Among Patients Hospitalized With COVID-19

Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference

Co-Occurrence of Post-Intensive Care Syndrome Problems Among 406 Survivors of Critical Illness*

Changes in hospital mortality for United States intensive care unit admissions from 1988 to 2012

The epidemiology of sepsis in the United States from 1979 through 2000

Recovery and outcomes after the acute respiratory distress syndrome (ARDS) in patients and their family caregivers

Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study

Long-term complications of critical care

The impact of sepsis, delirium, and psychological distress on self-rated cognitive function in ICU survivors-a prospective cohort study

mood and quality of life impairments in a select population of ARDS survivors

Physical and psychological sequelae of critical illness

Cooccurrence of and remission from general anxiety, depression, and posttraumatic stress disorder symptoms after acute lung injury: a 2-year longitudinal study

Co-Occurrence of Post-Intensive Care Syndrome Problems Among 406 Survivors of Critical Illness

Long-term cognitive impairment after critical illness

Long-term cognitive impairment and functional disability among survivors of severe sepsis

Prolonged cognitive dysfunction in survivors of critical illness

Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome

The relationship between cognitive performance and employment and health status in long-term survivors of the acute respiratory distress syndrome: results of an exploratory study

Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis

Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study

Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review

Postintensive Care Syndrome: Right Care, Right Now...and Later

An exploration of social and economic outcome and associated health-related quality of life after critical illness in general intensive care unit survivors: a 12-month follow-up study

Physical Impairments Associated With Post-Intensive Care Syndrome: Systematic Review Based on the World Health Organization's International Classification of Functioning, Disability and Health Framework

Prevalence and impact of frailty on mortality in elderly ICU patients: a prospective, multicenter, observational study

Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis

Anabolic and anticatabolic agents in critical care

Physical complications in acute lung injury survivors: a two-year longitudinal prospective study

A framework for diagnosing and classifying intensive care unit-acquired weakness

Muscle Weakness and 5-Year Survival in Acute Respiratory Distress Syndrome Survivors

An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults

Long-term association between frailty and health-related quality of life among survivors of critical illness: a prospective multicenter cohort study

The feasibility of measuring frailty to predict disability and mortality in older medical intensive care unit survivors

Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial

Hospital-Level Variation in Death for Critically Ill Patients with COVID-19

Survivorship after COVID-19 ICU stay

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis

Anxiety, Depression and Post Traumatic Stress Disorder after critical illness: a UK-wide prospective cohort study

Posttraumatic stress, anxiety and depression symptoms in patients during the first year post intensive care unit discharge

Suicide and self-harm in adult survivors of critical illness: population based cohort study

Interventions in Post-Intensive Care Syndrome-Family: A Systematic Literature Review

Predictors of symptoms of posttraumatic stress and depression in family members after patient death in the ICU

Quality of life after acute respiratory distress syndrome: a meta-analysis

Depressive symptoms and impaired physical function after acute lung injury: a 2-year longitudinal study

Posttraumatic stress disorder in general intensive care unit survivors: a systematic review

The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury

The impact of delirium in the intensive care unit on hospital length of stay

The relationship between executive dysfunction, depression, and mental health-related quality of life in survivors of critical illness: Results from the BRAIN-ICU investigation

Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit

Reducing iatrogenic risks: ICU-acquired delirium and weakness--crossing the quality chasm

Effectiveness and safety of the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility bundle

Staged Implementation of Awakening and Breathing, Coordination, Delirium Monitoring and Management, and Early Mobilization Bundle Improves Patient Outcomes and Reduces Hospital Costs

Five-Year Mortality and Hospital Costs Associated with Surviving Intensive Care

One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome

Mortality and costs following extracorporeal membrane oxygenation in critically ill adults: a population-based cohort study

Impact of Critical Illness on Resource Utilization: A Comparison of Use in the Year Before and After ICU Admission

One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome

Quality of life in the five years after intensive care: a cohort study

Depression, post-traumatic stress disorder, and functional disability in survivors of critical illness in the BRAIN-ICU study: a longitudinal cohort study

Physical declines occurring after hospital discharge in ARDS survivors: a 5-year longitudinal study

Changes in health-related quality of life after discharge from an intensive care unit: a systematic review

Health-related quality of life in ICU survivors-10 years later

Quality of life after intensive care: a systematic review of the literature

Functional Disability 5 Years after Acute Respiratory Distress Syndrome

Frailty and the Prediction of Negative Health Outcomes: A Meta-Analysis

Prevalence and Course of Frailty in Survivors of Critical Illness

Readmission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System

High-dimensional characterization of post-acute sequelae of COVID-19

Post-discharge persistent symptoms and healthrelated quality of life after hospitalization for COVID-19

Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis

Association of Social and Demographic Factors With COVID-19 Incidence and Death Rates in the US

Socioeconomic Position and Health Outcomes Following Critical Illness

Association of social deprivation with 1-year outcome of ICU survivors: results from the FROG-ICU study

Return to Employment after Critical Illness and Its Association with Psychosocial Outcomes. A Systematic Review and Meta-Analysis

Return to work after critical illness: a systematic review and meta-analysis

Joblessness and Lost Earnings after Acute Respiratory Distress Syndrome in a 1-Year National Multicenter Study

Financial Toxicity After Acute Respiratory Distress Syndrome: A National Qualitative Cohort Study*

Continuing Cardiopulmonary Symptoms, Disability, and Financial Toxicity 1 Month After Hospitalization for Third-Wave COVID-19: Early Results From a US Nationwide Cohort

An exploration of social and economic outcome and associated health-related quality of life after critical illness in general intensive care unit survivors: a 12-month follow-up study

Psychological Sequelae in Family Caregivers of Critically III Intensive Care Unit Patients. A Systematic Review

Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care

Post-ICU Clinics Should Be Staffed by ICU Clinicians

A UK survey of rehabilitation following critical illness: implementation of NICE Clinical Guidance 83 (CG83) following hospital discharge

Society of Critical Care Medicine's International Consensus Conference on Prediction and Identification of Long-Term Impairments After Critical Illness

Caring for Survivors of Critical Illness: Current Practices and the Role of the Nurse in Intensive Care Unit Aftercare

Randomized Clinical Trial of an ICU Recovery Pilot Program for Survivors of Critical Illness

Should ICU clinicians follow patients after ICU discharge? Yes

Should ICU clinicians follow patients after ICU discharge? No. Intensive Care Med

Key mechanisms by which post-ICU activities can improve in-ICU care: results of the international THRIVE collaboratives

Understanding the patient journey: a mechanism to reduce staff burnout?

Core Outcome Measures for Clinical Research in Acute Respiratory Failure Survivors. An International Modified Delphi Consensus Study

Rapid Design and Implementation of Post-COVID-19 Clinics

Post-ICU Recovery Clinics in the Era of Digital Health and Telehealth

Evidence-Based Cognitive Rehabilitation: Systematic Review of the Literature From

Effectiveness of cognitive interventions on cognitive outcomes of adult intensive care unit survivors: A scoping review

Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Physical rehabilitation for critical illness myopathy and neuropathy: an abridged version of Cochrane Systematic Review

The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial

Increased Hospital-Based Physical Rehabilitation and Information Provision After Intensive Care Unit Discharge: The RECOVER Randomized Clinical Trial

Effectiveness of an exercise programme on physical function in patients discharged from hospital following critical illness: a randomised controlled trial (the REVIVE trial)

Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment

Long-Haul COVID

Respiratory follow-up of patients with COVID-19 pneumonia

Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia

Comprehensive Health Assessment 3 Months After Recovery From Acute Coronavirus Disease 2019 (COVID-19)

Recovery of pulmonary functions, exercise capacity, and quality of life after pulmonary rehabilitation in survivors of ARDS due to severe influenza A (H1N1) pneumonitis

Major depressive disorder: new clinical, neurobiological, and treatment perspectives

Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis

Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a metaanalysis

Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity

Summary of the clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults

Benefits of Peer Support for Intensive Care Unit Survivors: Sharing Experiences, Care Debriefing, and Altruism

Peer Support Group for Intensive Care Unit Survivors: Perceptions on Supportive Recovery in the Era of Social Distancing

One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome

Key Components of ICU Recovery Programs: What Did Patients Report Provided Benefit?

Key mechanisms by which post-ICU activities can improve in-ICU care: results of the international THRIVE collaboratives

Challenges in conducting long-term outcomes studies in critical care